- Home
- KIRK vs LGVN Comparison
KIRK vs LGVN Comparison
Compare KIRK & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIRK
- LGVN
- Stock Information
- Founded
- KIRK 1966
- LGVN 2014
- Country
- KIRK United States
- LGVN United States
- Employees
- KIRK N/A
- LGVN N/A
- Industry
- KIRK Diversified Commercial Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- KIRK Miscellaneous
- LGVN Health Care
- Exchange
- KIRK Nasdaq
- LGVN Nasdaq
- Market Cap
- KIRK 25.9M
- LGVN 28.4M
- IPO Year
- KIRK 2002
- LGVN 2021
- Fundamental
- Price
- KIRK $1.70
- LGVN $1.65
- Analyst Decision
- KIRK Buy
- LGVN Strong Buy
- Analyst Count
- KIRK 2
- LGVN 3
- Target Price
- KIRK $4.50
- LGVN $8.67
- AVG Volume (30 Days)
- KIRK 209.8K
- LGVN 319.6K
- Earning Date
- KIRK 12-06-2024
- LGVN 11-12-2024
- Dividend Yield
- KIRK N/A
- LGVN N/A
- EPS Growth
- KIRK N/A
- LGVN N/A
- EPS
- KIRK N/A
- LGVN N/A
- Revenue
- KIRK $458,411,000.00
- LGVN $1,852,000.00
- Revenue This Year
- KIRK N/A
- LGVN $161.78
- Revenue Next Year
- KIRK $0.72
- LGVN $40.89
- P/E Ratio
- KIRK N/A
- LGVN N/A
- Revenue Growth
- KIRK N/A
- LGVN 141.46
- 52 Week Low
- KIRK $1.39
- LGVN $0.77
- 52 Week High
- KIRK $3.50
- LGVN $21.30
- Technical
- Relative Strength Index (RSI)
- KIRK 44.43
- LGVN 31.55
- Support Level
- KIRK $1.70
- LGVN $1.80
- Resistance Level
- KIRK $1.85
- LGVN $2.15
- Average True Range (ATR)
- KIRK 0.13
- LGVN 0.13
- MACD
- KIRK -0.01
- LGVN -0.03
- Stochastic Oscillator
- KIRK 2.42
- LGVN 0.00
About KIRK Kirkland's Inc. COMMONSTOCK
Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.